Amgen Will Cut Jobs | Chemical & Engineering News
Volume 85 Issue 34 | p. 25 | Concentrates
Issue Date: August 20, 2007

Amgen Will Cut Jobs

Department: Business | Collection: Economy

Amgen, the world's largest biotechnology company, will reduce staffing by 12-14% in response to lower sales of Aranesp, its erythropoiesis-stimulating agent (see page 34). The move will cost the company up to $700 million and result in the loss of 2,200 to 2,600 jobs. Despite the cuts, Amgen says it will continue to invest in R&D at "industry-leading levels."

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment